Mathematical modeling of tumor therapy with oncolytic viruses: Effects of parametric heterogeneity on cell dynamics

Biology Direct

Volumn 1, Issue , 2006, Pages

  Karev, Georgy P ^a   Novozhilov, Artem S ^a   Koonin, Eugene V ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248141607     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-1-30     Document Type: Article

References (66)

1. Kitano H Cancer robustness: Tumour tactics Nature 2003 426 6963 125 10.1038/426125a 14614483
2. Kitano H Cancer as a robust system: Implications for anticancer therapy Nat Rev Cancer 2004 4 3 227-235 10.1038/nrc1300 14993904
3. Alexandrova R Tumour heterogeneity Exper Path and Paras 2001 4 6 57-67
4. Gonzalez-Garcia I Sole RV Costa J Metapopulation dynamics and spatial heterogeneity in cancer Proc Natl Acad Sci U S A 2002 99 20 13085-13089 130590 12351679 10.1073/pnas.202139299
5. Maley CC Galipeau PC Finley JC Wongsurawat VJ Li X Sanchez CA Paulson TG Blount PL Risques RA Rabinovitch PS Reid BJ Genetic clonal diversity predicts progression to esophageal adenocarcinoma Nat Genet 2006 38 4 468-473 10.1038/ng1768 16565718
6. Maley CC Reid BJ Natural selection in neoplastic progression of Barrett's esophagus Semin Cancer Biol 2005 15 6 474-483 10.1016/ j.semcancer.2005.06.004 16043360
7. Heppner GH Tumor heterogeneity Cancer Res 1984 44 6 2259-2265 6372991
8. Heppner GH Miller FR The cellular basis of tumor progression Int Rev Cytol 1998 177 1-56 9378615
9. Harris JF Chambers AF Ling V Hill RP Dynamic heterogeneity: characterization of two cell lines derived from experimental lung metastases of mouse KHT fibrosarcoma Invasion Metastasis 1987 7 4 217-229 3667144
10. Hill RP Chambers AF Ling V Harris JF Dynamic heterogeneity: Rapid generation of metastatic variants in mouse B16 melanoma cells Science 1984 224 4652 998-1001 10.1126/science.6719130 6719130
11. Nowell PC Mechanisms of tumor progression Cancer Res 1986 46 5 2203-2207 3516380
12. Gorunova L Dawiskiba S Andren-Sandberg A Hoglund M Johansson B Extensive cytogenetic heterogeneity in a benign retroperitoneal schwannoma Cancer Genet Cytogenet 2001 127 2 148-154 10.1016/S0165-4608(00)00440-4 11425455
13. Fujii H Yoshida M Gong ZX Matsumoto T Hamano Y Fukunaga M Hruban RH Gabrielson E Shirai T Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity Cancer Res 2000 60 1 114-120 10646862
14. Goldie JH Coldman AJ A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 1979 63 11-12 1727-1733 526911
15. Skipper HE Schabel FMJ Tumor stem cell heterogeneity: Implications with respect to classification of cancers by chemotherapeutic effect Cancer Treat Rep 1984 68 1 43-61 6692436
16. Moolgavkar SH Knudson AGJ Mutation and cancer: A model for human carcinogenesis J Natl Cancer Inst 1981 66 6 10370-1052 6941039
17. Michor F Iwasa Y Nowak MA Dynamics of cancer progression Nat Rev Cancer 2004 4 3 197-205 10.1038/nrc1295 14993901
18. Preziosi L Cancer Modeling and Simulation Boca Raton, FL, CRC 2003
19. Gatenby RA Models of Tumor-Host Interaction as Competing Populations: Implications for Tumor Biology and Treatment Journal of Theoretical Biology 1995 176 4 447-455 10.1006/jtbi.1995.0212 8551743
20. Gatenby RA Vincent TL An evolutionary model of carcinogenesis Cancer Res 2003 63 19 6212-6220 14559806
21. Gatenby RA Vincent TL Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies Mol Cancer Ther 2003 2 9 919-927 14555711
22. Wodarz D Komarova N Computational biology of cancer World Scientific 2005
23. Komarova NL Mathematical modeling of tumorigenesis: Mission possible Curr Opin Oncol 2005 17 1 39-43 10.1097/01.cco.0000143681.37692.32 15608511
24. Goldie JH Coldman AJ Drug Resistance in Cancer: Mechanisms and Models Cambridge University Press 1998
25. Martin R Teo KL Optimal control of drug administration in cancer chemotherapy World Scientific Publishing 1993
26. de Pillis LG Gu W Radunskaya AE Mixed immunotherapy and chemotherapy of tumors: Modeling, applications and biological interpretations Journal of Theoretical Biology 2006 238 4 841-862 10.1016/j.jtbi.2005.06.037 16153659
27. Liu W Freedman HI A mathematical model of vascular tumor treatment by chemotherapy Mathematical and Computer Modelling 2005 42 9-10 1089-1112 10.1016/j.mcm.2004.09.008
28. Birkhead BG Rankin EM Gallivan S Dones L Rubens RD A mathematical model of the development of drug resistant to cancer chemotherapy European Journal of Cancer and Clinical Oncology 1987 23 9 1421-1427 10.1016/ 0277-5379(87)90133-7
29. Lakmeche A Arino O Nonlinear mathematical model of pulsed-therapy of heterogeneous tumors Nonlinear Analysis: Real World Applications 2001 2 4 455-465 10.1016/S1468-1218(01)00003-7
30. Norris ES King JR Byrne HM Modelling the response of spatially structured tumours to chemotherapy: Drug kinetics Mathematical and Computer Modelling In Press, Corrected Proof
31. Stephanou A McDougall SR Anderson ARA Chaplain MAJ Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies Mathematical and Computer Modelling 2005 41 10 1137-1156 10.1016/j.mcm.2005.05.008
32. Chaplain MAJ Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development Mathematical and Computer Modelling 1996 23 6 4787 10.1016/ 0895-7177(96)00019-2
33. Lankelma J Fernandez Luque R Dekker H Pinedo HM Simulation model of doxorubicin activity in islets of human breast cancer cells Biochim Biophys Acta 2003 1622 3 169-178 12928113
34. Drasdo D Hohme S Individual-based approaches to birth and death in avascu1ar tumors Mathematical and Computer Modelling 2003 37 11 1163-1175 10.1016/S0895-7177(03)00128-6
35. Quaranta V Weaver AM Cummings PT Anderson ARA Mathematical modeling of cancer: The future of prognosis and treatment Clinica Chimica Acta 2005 357 2 173-179 10.1016/j.cccn.2005.03.023
36. Kirn DH McCormick F Replicating viruses as selective cancer therapeutics Mol Med Today 1996 2 12 519-527 10.1016/S1357-4310(97)81456-6 9015793
37. Parato KA Senger D Forsyth PA Bell JC Recent progress in the battle between oncolytic viruses and tumours Nat Rev Cancer 2005 5 12 965-976 10.1038/nrc1750 16294217
38. McCormick F Cancer-specific viruses and the development of ONYX-015 Cancer Biol Ther 2003 2 4 Suppl 1 S157-60 14508094
39. Kasuya H Takeda S Nomoto S Nakao A The potential of oncolytic virus therapy for pancreatic cancer Cancer Gene Ther 2005 12 9 725-736 10.1038/ sj.cgt.7700830 15818382
40. Kaplan JM Adenovirus-based cancer gene therapy Curr Gene Ther 2005 5 6 595-605 10.2174/156652305774964677 16457649
41. Kirn D Hermiston T McCormick F ONYX-015: Clinical data are encouraging Nat Med 1998 4 12 1341-1342 10.1038/3902 9846551
42. Khuri FR Nemunaitis J Ganly I Arseneau J Tannock IF Romel L Gore M Ironside J MacDougall RH Heise C Randlev B Gillenwater AM Bruso P Kaye SB Hong WK Kirn DH a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat Med 2000 6 8 879-885 10.1038/78638 10932224
43. Nemunaitis J Khuri F Ganly I Arseneau J Posner M Vokes E Kuhn J McCarty T Landers S Blackburn A Romel L Randlev B Kaye S Kirn D Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer J Clin Oncol 2001 19 2 289-298 11208818
44. Shah AC Benos D Gillespie GY Markert JM Oncolytic viruses: Clinical applications as vectors for the treatment of malignant gliomas J Neurooncol 2003 65 3 203-226 10.1023/B:NEON.0000003651.97832.6c 14682372
45. Kaufman HL Deraffele G Mitcham J Moroziewicz D Cohen SM Hurst-Wicker KS Cheung K Lee DS Divito J Voulo M Donovan J Dolan K Manson K Panicali D Wang E Horig H Marincola FM Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma J Clin Invest 2005 115 7 1903-1912 1142116 15937544 10.1172/JCI24624
46. Reid T Warren R Kirn D Intravascular adenoviral agents in cancer patients: Lessons from clinical trials Cancer Gene Ther 2002 9 12 979-986 10.1038/sj.cgt.7700539 12522437
47. Shen Y Nemunaitis J Herpes simplex virus 1 (HSV-1) for cancer treatment Cancer Gene Ther 2006 16604059
48. Thorne SH Negrin RS Contag CH Synergistic antitumor effects of immune cell-viral biotherapy Science 2006 311 5768 1780-1784 10.1126/ science.1121411 16556847
49. Harrison D Sauthoff H Heitner S Jagirdar J Rom WN Hay JG Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved - deletion of the viral E1b-19-kD gene increases the viral oncolytic effect Hum Gene Ther 2001 12 10 1323-1332 10.1089/104303401750270977 11440625
50. Lorence RM Pecora AL Major PP Hotte SJ Laurie SA Roberts MS Groene WS Bamat MK Overview of phase I studies of intravenous administration of PV701, an oncolytic virus Curr Opin Mol Ther 2003 5 6 618-624 14755888
51. Novozhilov AS Berezovskaya FS Koonin EV Karev GP Mathematical modeling of tumor therapy with oncolytic viruses: Regimes with complete tumor elimination within the framework of deterministic models Biology Direct 2006
52. Wodarz D Viruses as antitumor weapons: Defining conditions for tumor remission Cancer Res 2001 61 8 3501-3507 11309314
53. Nowak MA May RM Virus Dynamics: Mathematical principles of immunology and virology New-York, Oxford 2000
54. Tao Y Guo Q The competitive dynamics between tumor cells, a replication-competent virus and an immune response J Math Biol 2005 51 1 3774 10.1007/s00285-004-0310-6 15772825
55. Dyson J Villella-Bressan R Webb GF Asynchronous exponential growth in an age structured population of proliferating and quiescent cells Mathematical Biosciences 2002 177-178 73-83 10.1016/ S0025-5564(01)00097-9 11965249
56. Dushoff J Host Heterogeneity and Disease Endemicity: A Moment-Based Approach Theoretical Population Biology 1999 56 3 325-335 10.1006/ tpbi.1999.1428 10607525
57. Hsu Schmitz SF Effects of genetic heterogeneity on HIV transmission in homosexual populations Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods and Theory Springer-Verlag Castillo-Chavez C, Blower S, van den Driessche P, Kirschner D, Yakubu AA 2002 245-260
58. Dushoff J Levin S The effects of population heterogeneity on disease invasion Mathematical Biosciences 1995 128 1-2 25-40 10.1016/ 0025-5564(94)00065-8 7606137
59. Ackleh AS Estimation of rate distributions in generalized Kolmogorov community models Nonlinear Analysis 1998 33 7 729-745 10.1016/ S0362-546X(97)00665-2
60. Diekmann O Heesterbeek H Metz H The Legacy of Kermack and McKendrick Epidemic Models: Their Structure and Relation to Data Mollison D 1995 95-115
61. Karev G The effects of non-homogeneity in population dynamics Doklady Matematica 2000 62 141-145
62. Karev G Dynamics of heterogeneous populations and communities and evolution of distributions Dis and Cont Dyn Sys 2005 Suppl 487-496
63. Veliov VM Newton's method for problems of optimal control of heterogeneous systems Optimization Methods & Software 2003 18 6 689-703 10.1080/10556780310001639753
64. Ackleh AS Marshall DF Heatherly HE Fitzpatrick BG Survival of the fittest in a generalized logistic model Mathematical Models & Methods in Applied Sciences 1999 9 9 1379-1391 10.1142/S0218202599000610
65. Novozhilov AS Analysis of a generalized population predator-prey model with a parameter distributed normally over the individuals in the predator population Journal of Computer and Systems Sciences International 2004 43 3 378-382
66. Veliov VM On the effect of population heterogeneity on dynamics of epidemic diseases J of Math Bio 2005 51 123-143 10.1007/s00285-004-0288-0